Is the Expression of Androgen Receptor Protein Associated With the Length of AC Repeats in the Type III 5-α Reductase Gene in Prostate Cancer Patients?

다국어 초록 (Multilingual Abstract)

Purpose: Type III 5-α reductase (SRD5A3; steroid 5-α reductase 3) may be associated with the progression of prostate cancer (PCa). The aim of our study was to determine whether the length of AC repeats in the SRD5A3 gene is associated with the risk of PCa and the expression of androgen receptor (AR) protein in Korean men.
Materials and Methods: We compared the length of AC repeats in the short tandem repeat (STR) region of the SRD5A3 gene in 68 PCa patients and 81 control subjects by genotyping. A total of 55 patients in the PCa group underwent radical prostatectomy.
We evaluated the expression of AR protein by using Western blotting and tested the association between the type of AC repeats in the SRD5A3 gene and AR protein expression and clinical and pathologic parameters.
Results: The short type of STR had less than 21 copies of AC repeats in the SRD5A3gene. The SS type (short and short type) of STR of the SRD5A3 gene was 2.2 times as likely to occur in PCa patients as in controls (odds ratio, 2.21; 95% confidence interval,1.14 to 4.31; p=0.019). However, AC repeats of the SRD5A3 gene were not associated with AR protein expression or clinical or pathologic parameters in PCa samples.
Conclusions: These results suggest that the short AC repeats of SRD5A3 polymorphism are associated with an increased risk of PCa. SRD5A3 polymorphism may contribute to a genetic predisposition for PCa.

참고문헌 (Reference)

1 Riley DE, "Transcribed short tandem repeats occur in couples with strongly preferred registers" 305 : 257-265, 2003

2 Muir CS, "The epidemiology of prostatic cancer: geographical distribution and time-trends" 30 : 133-140, 1991

3 Cindolo L, "The effects of dutasteride and finasteride on BPH-related hospitalization, surgery and prostate cancer diagnosis: a record-linkage analysis" 2012

4 Riley DE, "Short tandem repeats are associated with diverse mRNAs encoding membrane-targeted proteins" 26 : 434-444, 2004

5 Riley DE, "Short tandem repeat (STR) replacements in UTRs and introns suggest an important role for certain STRs in gene expression and disease" 344 : 203-211, 2005

6 Park SK, "Rising prostate cancer rates in South Korea" 66 : 1285-1291, 2006

7 Barnholtz-Sloan JS, "Replication of GWAS "Hits" by Race for Breast and Prostate Cancers in European Americans and African Americans" 2 : 37-, 2011

8 Mohler JL, "Prostate cancer, Version 3.2012: featured updates to the NCCN guidelines" 10 : 1081-1087, 2012

9 Uemura M, "Novel 5 alpha-steroid reductase (SRD5A3, type-3) is overexpressed in hormone-refractory prostate cancer" 99 : 81-86, 2008

10 Sudduth SL, "Finasteride: the first 5 alpha-reductase inhibitor" 13 : 309-325, 1993

11 Riley DE, "Diverse eukaryotic transcripts suggest short tandem repeats have cellular functions" 298 : 581-586, 2002

12 Mitsiades N, "Distinct patterns of dysregulated expression of enzymes involved in androgen synthesis and metabolism in metastatic prostate cancer tumors" 72 : 6142-6152, 2012

13 Andriole G, "Dihydrotestosterone and the prostate: the scientific rationale for 5alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia" 172 (172): 1399-1403, 2004

14 Thomas LN, "Differential alterations in 5alpha-reductase type 1 and type 2 levels during development and progression of prostate cancer" 63 : 231-239, 2005

15 Luo J, "Decreased gene expression of steroid 5 alpha-reductase 2 in human prostate cancer: implications for finasteride therapy of prostate carcinoma" 57 : 134-139, 2003

16 Siegel R, "Cancer statistics, 2012" 62 : 10-29, 2012

17 Siegel R, "Cancer statistics for Hispanics/Latinos, 2012" 62 : 283-298, 2012

18 Li J, "Androgen regulation of 5a-reductase isoenzymes in prostate cancer: implications for prostate cancer prevention" 6 : e28840-, 2011

19 Kleiman FE, "A frequent TG deletion near the polyadenylation signal of the human HEXB gene: occurrence of an irregular DNA structure and conserved nucleotide sequence motif in the 3' untranslated region" 12 : 320-329, 1998

20 Steers WD, "5alpha-reductase activity in the prostate" 58 (58): 17-24, 2001

21 Godoy A, "5a-reductase type 3 expression in human benign and malignant tissues: a comparative analysis during prostate cancer progression" 71 : 1033-1046, 2011